Balversa 3 MG
Ended Awarded
- Contract number
- 36C24525N0190
- Awardee
-
Janssen Biotech Inc. UEI NVYMGFA53MN7
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $13,639
Award facts
- Contract value 100% obligated
- $13,639.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed price delivery order contract awarded to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., by the Department of Veterans Affairs (VA). The contract has an ultimate completion date of November 22, 2024 and a ceiling value of $13,639.07. The contract is for the provision of the oncology drug BALVERSA (erdafitinib) to support healthcare services for veterans through the VA's Veterans Health Administration (VHA).
Janssen Biotech is a major pharmaceutical manufacturer that specializes in biologic therapies, including for cancer treatment. This contract is not set aside and is awarded against Janssen's $3.1 billion Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs, as well as a $15 million Blanket Purchase Agreement (BPA) specifically for BALVERSA and another $3.7 million BPA for BALVERSA and WELIREG. These contract vehicles enable the VA and its Veterans Integrated Service Networks (VISNs) to efficiently procure critical oncology medications to treat veteran patients nationwide.
Quick answers
Who was awarded contract 36C24525N0190?
36C24525N0190 was awarded to Janssen Biotech Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on November 20, 2024.
How much is contract 36C24525N0190 worth?
The government has obligated $13,639 on 36C24525N0190.
Is contract 36C24525N0190 an order under another contract?
Yes. 36C24525N0190 is a delivery order under 36F79724D0176, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0190 competed?
The extent of competition for 36C24525N0190 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award